Role of artificial intelligence in the care of patients with nonsmall cell lung cancer.

Journal: European journal of clinical investigation
Published Date: Feb 19, 2018

Abstract

BACKGROUND: Lung cancer is the leading cause of cancer death worldwide. In up to 57% of patients, it is diagnosed at an advanced stage and the 5-year survival rate ranges between 10%-16%. There has been a significant amount of research using machine learning to generate tools using patient data to improve outcomes.

Authors

  • Mohamad Rabbani
    McGill University Health Centre, McGill University, Montreal, QC, Canada.
  • Jonathan Kanevsky
    Montreal, Quebec, Canada; Boston, Mass.; and Albany, N.Y.
  • Kamran Kafi
    McGill University Health Centre, McGill University, Montreal, QC, Canada.
  • Florent Chandelier
    Department of Technology, Imagia, Montreal, Quebec, Canada.
  • Francis J Giles
    Developmental Therapeutics Consortium, Chicago, IL, USA.

Keywords

External Resources

Popular Topics
Recent Journals